title: IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults.
abstract: We tested independent and interactive contributions of a recently noted and promising insulin degrading enzyme polymorphism (IDE; rs6583817) and type 2 diabetes (T2D) to executive function performance, concurrently and longitudinally. Regarding normal neurocognitive decline and Alzheimer's disease, T2D is a known risk factor and this IDE variant might contribute risk or risk reduction via the minor (A) or major (G) allele. We compared normal aging and T2D groups (baseline n = 574; ages 53-95 years) over 2 longitudinal waves (mean interval = 4.4 years). We used confirmatory factor analysis, latent growth curve modeling, and path analysis. A confirmed single-factor model of 4 executive function tasks established the cognitive phenotype. This IDE variant predicted concurrent group differences and differential change in cognitive performance. Furthermore, the IDE major allele reduced risk of cognitive decline. T2D predicted performance only concurrently. Both IDE and T2D are associated with executive function levels in older adults, but only IDE moderated 2-wave change. Previously linked to Alzheimer's disease, this IDE variant should be further explored for its potential influence on cognitive phenotypes of normal aging.
authors.affiliation: Department of Psychology, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: G Peggy
authors.initials: GP
authors.lastname: McFall
authors.forename: Sandra A
authors.initials: SA
authors.lastname: Wiebe
authors.forename: David
authors.initials: D
authors.lastname: Vergote
authors.forename: David
authors.initials: D
authors.lastname: Westaway
authors.forename: Jack
authors.initials: J
authors.lastname: Jhamandas
authors.forename: Roger A
authors.initials: RA
authors.lastname: Dixon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000235:genetics / Q000523:psychology; D000483:Alleles; D000544:Alzheimer Disease / Q000235:genetics; D003071:Cognition / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics* / Q000523:psychology*; D056344:Executive Function / Q000502:physiology*; D005260:Female; D006801:Humans; D007339:Insulysin / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D012307:Risk Factors
chemical_list: D007339:Insulysin